Oral immunotherapy and tolerance induction in childhood

Pediatric Allergy and Immunology

Volumn 24, Issue 6, 2013, Pages 512-520

  Tang, M L K ^a,b,c   Martino, D J ^a  

^a MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Childhood; Desensitization; Food allergy; Oral immunotherapy; Oral tolerance

Indexed keywords

FOOD ANTIGEN;

ARTICLE; CHILD CARE; DESENSITIZATION; FOOD ALLERGY; HUMAN; ORAL IMMUNOTHERAPY; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL (TOPIC);

CHILDHOOD; DESENSITIZATION; FOOD ALLERGY; ORAL IMMUNOTHERAPY; ORAL TOLERANCE;

ADMINISTRATION, ORAL; ADULT; ANIMALS; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; DESENSITIZATION, IMMUNOLOGIC; FOOD HYPERSENSITIVITY; HUMANS; IMMUNE TOLERANCE;

EID: 84883148976     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/pai.12100     Document Type: Article

References (73)

1. Liew WK, Williamson E, Tang ML. Anaphylaxis fatalities and admissions in Australia. J Allergy Clin Immunol 2009: 123: 434-42.
2. Wells HG, Osborne TB. The biological reactions of the vegetable proteins. I. Anaphylaxis. J Infect Dis 1911: 8: 66-124.
3. Miller A, Lider O, Roberts AB, Sporn MB, Weiner HL. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc Natl Acad Sci USA 1992: 89: 421-5.
4. Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994: 265: 1237-40.
5. Friedman A, Weiner HL. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc Natl Acad Sci USA 1994: 91: 6688-92.
6. Chen Y, Inobe J, Marks R, Gonnella P, Kuchroo VK, Weiner HL. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 1995: 376: 177-80.
7. Curotto de Lafaille MA, Kutchukhidze N, Shen S, Ding Y, Yee H, Lafaille JJ. Adaptive Foxp3+ regulatory T cell-dependent and -independent control of allergic inflammation. Immunity 2008: 29: 114-26.
8. Hadis U, Wahl B, Schulz O, et al. Intestinal tolerance requires gut homing and expansion of FoxP3+ regulatory T cells in the lamina propria. Immunity 2011: 34: 237-46.
9. Mucida D, Kutchukhidze N, Erazo A, Russo M, Lafaille JJ, Curotto de Lafaille MA. Oral tolerance in the absence of naturally occurring Tregs. J Clin Invest 2005: 115: 1923-33.
10. Garside P, Steel M, Liew FY, Mowat AM. CD4+ but not CD8+ T cells are required for the induction of oral tolerance. Int Immunol 1995: 7: 501-4.
11. Schulz O, Jaensson E, Persson EK, et al. Intestinal CD103+, but not CX3CR1+, antigen sampling cells migrate in lymph and serve classical dendritic cell functions. J Exp Med 2009: 206: 3101-14.
12. Bogunovic M, Ginhoux F, Helft J, et al. Origin of the lamina propria dendritic cell network. Immunity 2009: 31: 513-25.
13. Niess JH, Brand S, Gu X, et al. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 2005: 307: 254-8.
14. Worbs T, Bode U, Yan S, et al. Oral tolerance originates in the intestinal immune system and relies on antigen carriage by dendritic cells. J Exp Med 2006: 203(3): 519-27.
15. Fukaya T, Takagi H, Sato Y, et al. Crucial roles of B7-H1 and B7-DC expressed on mesenteric lymph node dendritic cells in the generation of antigen-specific CD4+ Foxp3+ regulatory T cells in the establishment of oral tolerance. Blood 2010: 116: 2266-76.
16. Matteoli G, Mazzini E, Iliev ID, et al. Gut CD103+ dendritic cells express indoleamine 2, 3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction. Gut 2010: 59: 595-604.
17. Weiner HL, da Cunha AP, Quintana F, Wu H. Oral tolerance. Immunol Rev 2011: 241: 241-59.
18. Akdis M, Verhagen J, Taylor A, et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med 2004: 199: 1567-75.
19. Beyer K, Castro R, Birnbaum A, Benkov K, Pittman N, Sampson HA. Human milk-specific mucosal lymphocytes of the gastrointestinal tract display a TH2 cytokine profile. J Allergy Clin Immunol 2002: 109: 707-13.
20. Flinterman AE, Pasmans SG, den Hartog Jager CF, et al. T cell responses to major peanut allergens in children with and without peanut allergy. Clin Exp Allergy 2010: 40: 590-7.
21. Turcanu V, Maleki SJ, Lack G. Characterization of lymphocyte responses to peanuts in normal children, peanut-allergic children, and allergic children who acquired tolerance to peanuts. J Clin Invest 2003: 111: 1065-72.
22. Tiemessen MM, Van Ieperen-Van Dijk AG, Bruijnzeel-Koomen CA, Garssen J, Knol EF, Van Hoffen E. Cow's milk-specific T-cell reactivity of children with and without persistent cow's milk allergy: key role for IL-10. J Allergy Clin Immunol 2004: 113: 932-9.
23. Dorion BJ, Burks AW, Harbeck R. The production of interferon-gamma in response to a major peanut allergy, Ara h II correlates with serum levels of IgE anti-Ara h II. J Allergy Clin Immunol 1994: 93(1 Pt 1): 93-9.
24. Perez-Machado MA, Ashwood P, Thomson MA, et al. Reduced transforming growth factor-beta1-producing T cells in the duodenal mucosa of children with food allergy. Eur J Immunol 2003: 33: 2307-15.
25. Smith M, Tourigny MR, Noakes P, Thornton CA, Tulic MK, Prescott SL. Children with egg allergy have evidence of reduced neonatal CD4+ CD25+ CD127lo/- regulatory T cell function. J Allergy Clin Immunol 2008: 121: 1460-6.
26. Karlsson MR, Rugtveit J, Brandtzaeg P. Allergen-responsive CD4+ CD25+ regulatory T cells in children who have outgrown cow's milk allergy. J Exp Med 2004: 199: 1679-88.
27. Delong JH, Simpson KH, Wambre E, James EA, Robinson D, Kwok WW. Ara h 1-reactive T cells in individuals with peanut allergy. J Allergy Clin Immunol 2011: 127: 1211-8.e3.
28. Thottingal TB, Stefura BP, Simons FER, et al. Human subjects without peanut allergy demonstrate T cell-dependent, TH2-biased, peanut-specific cytokine and chemokine responses independent of TH1 expression. J Allergy Clin Immunol 2006: 118: 905-14.
29. Savilahti EM, Karinen S, Salo HM, et al. Combined T regulatory cell and Th2 expression profile identifies children with cow's milk allergy. Clin Immunol 2010: 136: 16-20.
30. Shreffler WG, Wanich N, Moloney M, Nowak-Wegrzyn A, Sampson HA. Association of allergen-specific regulatory T cells with the onset of clinical tolerance to milk protein. J Allergy Clin Immunol 2009: 123: 43-52.e7.
31. Plaut M, Sawyer RT, Fenton MJ. Summary of the 2008 National Institute of Allergy and Infectious Diseases-US Food and Drug Administration Workshop on Food Allergy Clinical Trial Design. J Allergy Clin Immunol 2009: 124: 671-8.e1.
32. Schofield AT. A case of egg poisoning. Lancet 1908: 171: 716.
33. Bauer A, Ekanayake Mudiyanselage S, Wigger-Alberti W, Elsner P, et al. Oral rush desensitization to milk. Allergy 1999: 54: 894-5.
34. Nucera E, Schiavino D, D'Ambrosio C, et al. Immunological aspects of oral desensitization in food allergy. Dig Dis Sci 2000: 45: 637-41.
35. Ismail IH, Tang ML. Oral immunotherapy for the treatment of food allergy. Isr Med Assoc J 2012: 14: 63-9.
36. Morisset M, Moneret-Vautrin DA, Guenard L, et al. Oral desensitization in children with milk and egg allergies obtains recovery in a significant proportion of cases. A randomized study in 60 children with cow's milk allergy and 90 children with egg allergy. Eur Ann Allergy Clin Immunol 2007: 39: 12-9.
37. Varshney P, Jones SM, Scurlock AM, et al. A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response. J Allergy Clin Immunol 2011: 127: 654-60.
38. Hofmann AM, Scurlock AM, Jones SM, et al. Safety of a peanut oral immunotherapy protocol in children with peanut allergy. J Allergy Clin Immunol 2009: 124: 286-91, 291.e1-6.
39. Longo G, Barbi E, Berti I, et al. Specific oral tolerance induction in children with very severe cow's milk-induced reactions. J Allergy Clin Immunol 2008: 121: 343-7.
40. Skripak JM, Nash SD, Rowley H, et al. A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy. J Allergy Clin Immunol 2008: 122: 1154-60.
41. Martorell A, De la Hoz B, Ibanez MD, et al. Oral desensitization as a useful treatment in 2-year-old children with cow's milk allergy. Clin Exp Allergy 2011: 41: 1297-304.
42. Pajno GB, Caminiti L, Ruggeri P, et al. Oral immunotherapy for cow's milk allergy with a weekly up-dosing regimen: a randomized single-blind controlled study. Ann Allergy Asthma Immunol 2010: 105: 376-81.
43. Brozek JL, Terracciano L, Hsu J, et al. Oral immunotherapy for IgE-mediated cow's milk allergy: a systematic review and meta-analysis. Clin Exp Allergy 2012: 42: 363-74.
44. Buchanan AD, Green TD, Jones SM, et al. Egg oral immunotherapy in nonanaphylactic children with egg allergy. J Allergy Clin Immunol 2007: 119: 199-205.
45. Vickery BP, Pons L, Kulis M, Steele P, Jones SM, Burks AW, et al. Individualized IgE-based dosing of egg oral immunotherapy and the development of tolerance. Ann Allergy Asthma Immunol 2010: 105: 444-50.
46. Blumchen K, Ulbricht H, Staden U, et al. Oral peanut immunotherapy in children with peanut anaphylaxis. J Allergy Clin Immunol 2011: 126: 83-91.e1.
47. Staden U, Rolinck-Werninghaus C, Brewe F, Wahn U, Niggemann B, Beyer K, et al. Specific oral tolerance induction in food allergy in children: efficacy and clinical patterns of reaction. Allergy 2007: 62: 1261-9.
48. Burks AW, Jones SM, Wood RA, et al. Oral immunotherapy for treatment of egg allergy in children. N Engl J Med 2012: 367: 233-43.
49. Keet CA, Frischmeyer-Guerrerio PA, Thyagarajan A, et al. The safety and efficacy of sublingual and oral immunotherapy for milk allergy. J Allergy Clin Immunol 2012: 129: 448-55, 455.e1-5.
50. Fisher HR, du Toit G, Lack G. Specific oral tolerance induction in food allergic children: is oral desensitisation more effective than allergen avoidance?: a meta-analysis of published RCTs. Arch Dis Child 2011: 96: 259-64.
51. Jones SM, Ponsz L, Roberts JL, et al. Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol 2009: 124: 292-300, 300.e1-97.
52. Alonso R, Zapatero L, Fuentes V, Barranco R, Davila G, Martinez M. Specific oral tolerance induction in 39 children with IgE mediated persistent cow's milk allergy. J Allergy Clin Immunol 2008: 121: S246.
53. Patriarca G, Nucera E, Roncallo C, et al. Oral desensitizing treatment in food allergy: clinical and immunological results. Aliment Pharmacol Ther 2003: 17: 459-65.
54. Meglio P, Giampietro PG, Gianni S, Galli E. Oral desensitization in children with immunoglobulin E-mediated cow's milk allergy-follow-up at 4 yr and 8 months. Pediatr Allergy Immunol 2008: 19: 412-9.
55. Vickery BP, Lin J, Kulis M, et al. Peanut oral immunotherapy modifies IgE and IgG4 responses to major peanut allergens. J Allergy Clin Immunol 2013: 131: 128-34.e1-3.
56. Urra JM, Garcia Rodriguez R, Feo Brito F, Mur P, Guerra F. Oral desensitization to egg enables CD4+ FoxP3+ cells to expand in egg-stimulated cells. J Investig Allergol Clin Immunol 2012: 22: 71-3.
57. Varshney P, Jones SM, Pons L, et al. Peanut Oral Immunotherapy (OIT) induces immunologic changes supporting the development of tolerance. J Allergy Clin Immunol 2010: 125: AB59 (Abstract).
58. Itoh N, Itagaki Y, Kurihara K. Rush specific oral tolerance induction in school-age children with severe egg allergy: one year follow up. Allergol Int 2010: 59: 43-51.
59. Barbi E, Longo G, Berti I, et al. Adverse effects during specific oral tolerance induction: in home phase. Allergol Immunopathol (Madr) 2012: 40: 41-50.
60. Varshney P, Steele PH, Vickery BP, et al. Adverse reactions during peanut oral immunotherapy home dosing. J Allergy Clin Immunol 2009: 124: 1351-2.
61. Blumchen K, Ulbricht H, Staden U, et al. Oral peanut immunotherapy in children with peanut anaphylaxis. J Allergy Clin Immunol 2010: 126: 83-91.e1.
62. Nadeau KC, Schneider LC, Hoyte L, Borras I, Umetsu DT. Rapid oral desensitization in combination with omalizumab therapy in patients with cow's milk allergy. J Allergy Clin Immunol 2011: 127: 1622-4.
63. Nadeau KC, Kohli A, Iyengar S, DeKruyff RH, Umetsu DT. Oral immunotherapy and anti-IgE antibody-adjunctive treatment for food allergy. Immunol Allergy Clin North Am 2012: 32: 111-33.
64. Lemon-Mule H, Sampson HA, Sicherer SH, Shreffler WG, Noone S, Nowak-Wegrzyn A, et al. Immunologic changes in children with egg allergy ingesting extensively heated egg. J Allergy Clin Immunol 2008: 122: 977-83.e1.
65. Nowak-Wegrzyn A, Bloom KA, Sicherer SH, et al. Tolerance to extensively heated milk in children with cow's milk allergy. J Allergy Clin Immunol 2008: 122: 342-7 .
66. Leonard SA, Sampson HA, Sicherer SH, et al. Dietary baked egg accelerates resolution of egg allergy in children. J Allergy Clin Immunol 2012: 130: 473-80.e1.
67. Leonard SA, Martos G, Wang W, Nowak-Wegrzyn A, Berin MC. Oral immunotherapy induces local protective mechanisms in the gastrointestinal mucosa. J Allergy Clin Immunol 2012: 129: 1579-87.e1.
68. Creticos PS, Schroeder JT, Hamilton RG, et al. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis. N Engl J Med 2006: 355: 1445-55.
69. Drachenberg KJ, Wheeler AW, Stuebner P, Horak F. A well-tolerated grass pollen-specific allergy vaccine containing a novel adjuvant, monophosphoryl lipid A, reduces allergic symptoms after only four preseasonal injections. Allergy 2001: 56: 498-505.
70. Simons FE, Shikishima Y, Van Nest G, Eiden JJ, HayGlass KT. Selective immune redirection in humans with ragweed allergy by injecting Amb a 1 linked to immunostimulatory DNA. J Allergy Clin Immunol 2004: 113: 1144-51.
71. Van Overtvelt L, Moussu H, Horiot S, et al. Lactic acid bacteria as adjuvants for sublingual allergy vaccines. Vaccine 2010: 28: 2986-92.
72. Mascarell L, Van Overtvelt L, Lombardi V, et al. A synthetic triacylated pseudo-dipeptide molecule promotes Th1/TReg immune responses and enhances tolerance induction via the sublingual route. Vaccine 2007: 26: 108-18.
73. Lombardi V, Van Overtvelt L, Horiot S, et al. Toll-like receptor 2 agonist Pam3CSK4 enhances the induction of antigen-specific tolerance via the sublingual route. Clin Exp Allergy 2008: 38: 1819-29.